Method Article
This article presents a protocol for executing the highly translational and independently proven mouse Stroke Unit (mSU) concept in large-stroke mice. It also provides a standardized protocol for executing the focal experimental stroke scale in mice, which evaluates stroke focal deficits detected even long-term.
The filament model of middle artery occlusion (fMCAo) is perhaps the most translational mouse stroke model, allowing for controlled ischemia with intravascular reperfusion/recanalization. However, it lacks alignment with current clinical advances for stroke care (e.g., Stroke Units), usually employs subjective or vague neurological scoring among laboratories, and exhibits high acute-phase mortality. Here, we address these limitations with validated video-guided protocols. We present the mouse Stroke Unit (mSU) protocol with instructional videos and a decision algorithm (Risk Stratification Score), bridging the gap between clinical and mouse stroke modeling. To increase accuracy and sensitivity of stroke neurological scoring, we present for the first time a video-standardized format of the focal Experimental Stroke Scale (fESS) and prove its value up to 6 months post-stroke. Additionally, protocols for mice Ladder-rung test, as well as the known Cylinder test, for unbiased, quantitative assessment of limbs´ motor function are presented. Results highlight mSU's translational efficacy. Focal ESS (fESS) excels over other known scales in detecting focal stroke deficits, capturing recovery, and maintaining sensitivity for up to 6 months post-stroke. Ladder-rung and Cylinder tests objectively quantify and monitor fore- and hind-limb motor deficits, long-term. In summary, integrating mSU, fESS, and motor function tests provides a robust framework for clinically relevant stroke investigations. Our protocols improve the translational value in mouse stroke research.
Large ischemic stroke is one of the major causes of morbidity and disability worldwide1. Still, mouse stroke research faces a translational block in almost all preclinically tested treatments so far2. The multiple reasons for this problem and the efforts to overcome it have been reviewed in detail in previous publication2. These challenges arise from the limited integration of clinical advances into relevant animal models2 and the weaknesses of behavioral and neurological scoring systems in detecting post-stroke deficits accurately and sensitively2.
Recent discoveries3 support that the filament model of middle artery occlusion (fMCAo) in mice has significant translational advantages over other models with open skull injury and trauma2,4. On top of that, this is the only one that models the reperfusion and mechanical thrombectomy of clinical stroke settings5,6,7. However, the model faces high subacute mortality between 3-7 days post-stroke, which prohibits long-term studies of large strokes and was considered until recently the model´s inherent and insurmountable artifact. In addition, the detection of post-stroke neurological deficits is relatively difficult and biased in mice due to their small size, especially among non-clinicians or inexperienced researchers8,9. To address this, different groups have developed various scales to detect deficits. The most used and known scales include the 3-point Bederson scale (BS)10, the 5-point modified Bederson scale (mBS)11, the 5-point Longa score (LS) (which is similar to mBS)6, the modified Neurological Stroke Scale (mNSS)12,13, the 18-point Garcia scale (GS)9 and the more detailed DeSimoni14 or differently known as "Neuroscore" (NS)9,15 scale. Unfortunately, some of these scales are either too crude and are restricted only to the few acute-phase days following stroke (BS, mBS and LS)8,9 or their interpretation is blurred by general deficits (NS).
With this background, we previously developed and validated the mouse Stroke Unit (mSU) support protocol, along with the experimental stroke scale (ESS) for mice13. The rationale for mSU was to adapt knowledge from the clinical routine (i.e., human stroke units) into preclinical research of stroke, while ESS critically consolidated previously existing but "insensitive" or redundant stroke scales into a practical, refined, sensitive and time-efficient one. The mSU consists of frequent and adapted monitoring of mouse´s basic clinical parameters with adapted application of animal support to enhance survival13.
Indeed, data from our laboratory and others verify the value of both methods. The mSU translates clinical basic supportive measures and advances7 from humans to mice, significantly reduces mortality of the fMCAo in mice from 60-70% to 10-15%13 thus allowing for studies of larger strokes, and can be effectively applied in independent laboratories since then16,17,18,19. In addition, the ESS can distinguish between focal (focal component of ESS, fESS) and general (general component of ESS, gESS) post-stroke deficits and symptoms, models the human clinical scoring (differentiation between focal and general signs and symptoms in humans), is linearly related to the stroke lesion size and is long-term sensitive to deficits13,20. Still, despite the proven value and efficacy of both mSU and ESS, the lack of clear-cut, visualized, standardized instructions for even inexperienced researchers leaves several open questions on mSU application and significant subjectivity on scoring focal deficits on fESS.
As such, our present article aims to provide video-assisted and clear instructions for mSU and fESS protocols. We strongly believe that it will support stroke researchers to increase the translational efficiency of their stroke studies, significantly reduce the loss of animals during the first 3-10 days after stroke, reduce experimentation costs, and eventually reproducibly evaluate neurological deficits for months after stroke13. Additionally, the add-on combination of the Ladder-rung test and Cylinder test can easily quantify the focal limb paresis (fore- and hindlimbs) due to fMCAo.
To showcase mSU and fESS efficiency, we provide medium- (14-days) and long-term (6-month) data on mice after fMCAo. Twelve-week-old male C57Bl/6J mice (n= 31) were used and housed under controlled temperature (22 ± 2 °C), with a 12 h light-dark cycle period and access to pelleted food and water ad libitum. Mice were divided into two cohorts followed for 14 days (n=10, cohort 1) and 6 months (n=15, cohort 2) respectively. These mice were subjected to a 60 min cerebral ischemia using the well-described model of fMCAo13,20,21 under isoflurane anesthesia. Sham-operated animals (n=6, operated as the above two cohorts, but no ischemia was induced) followed for 6 months served as controls. Buprenorphine was used as a pre- and 3-day post-operative analgesic. The Ladder rung and cylinder tests were also performed for the 6-month cohort as a part of the neurological scoring.
All animals were checked daily for humane endpoints during the first 14 days post-stoke, defined as: 1) severe hypothermia (<33 °C) and/or immobility (e.g., score 4 on Test 6 of fESS or "spontaneous activity" test of gESS) that was not improved by "mouse Stroke Unit" treatment (i.e., passive heating and active feeding, see 1.4, 1.6, 1.8) within one hour, 2) signs of pain or anxiety behavior (e.g. score >2 in "anxiety/automatic behavior" test of gESS), even after post-operative analgesia as per the protocol.
In this protocol, post-stroke support of the mice in the form of mSU begins immediately after mouse recovery from the fMCAo operation. This has 3 phases: phase A (0-48 h post-reperfusion), phase B (>48 h and up to the "end of needed active support", usually at day 10-14, depending on individual animal´s phase B), and phase C (day 14 onwards). It has five significant interventions (visits/Risk Stratification Score, feeding, fluids, temperature, and local disinfections; see 1.1. to 1.8. below) tailored to each animal, according to each phase (A, B or C) and its daily actual clinical status assessed by the Risk Stratification Score (RSS), see Supplementary Figure 1 and Table 1 with three typical examples. The required materials and tools for mSU are shown in Figure 1a and described in Table of Materials. We also provide a template for animal monitoring during mSU (see Supplementary File 1).
The experiments reported in this article were conducted following National and European guidelines for the use of experimental animals and were approved by the Greek governmental committees (Athens, License No "843895_06-09-2022").
1. The "mouse Stroke-Unit" (mSU)
2. The focal component of Experimental Stroke Scale (fESS)
3. General component of ESS (gESS)
NOTE: Assess the gESS to detect signs of "general mouse illness", e.g., inflammation or infection, usually present during the first 1-2 weeks post-fMCAo. Use the scoring sheet in Supplementary file 2. Assess gESS preferably after completing the fESS.
4. Quantification of forelimb deficits with the Cylinder Test
NOTE: Cylinder test is previously described in detail9,15,27 and will not be described in detail here. The cylinder test is an independent behavioral test that unbiased quantifies deficits of the forelimbs (see 4.2).
5. Quantification of fore- and hindlimb deficits with the Ladder-rung Test
NOTE: Construct the apparatus for mice out of Plexiglas (shown in Figure 3c): a 1 m long corridor with 20 cm high walls, plastic rungs (3mm diameter) placed at regular intervals of 15 mm (Figure 3c1) and a "refuge" box at the distal end. Place animal bedding in the refuge box for familiarity and some food pellets or peanut butter as a reward. The width of the corridor should be 10 cm and should be elevated approximately 30cm from ground.
The mSU, as described above, begins after the fMCAo operation. Our representative results in the two independent mouse cohorts of fMCAo stroke and sham (Figure 4a) confirms the previously proven value of mSU, particularly during the critical period between days 3 and 1013. In our cohorts, mortality occurred for 3/15 animals of Cohort 1 (stroked, 6 months follow-up), 2/10 of Cohort 2 (stroked, 14 days follow-up), and 0/6 of sham-operated animals (Figure 4a) as part of stroke pathophysiology (all found dead during the morning visits), and was included in the scoring. No animals were euthanized per predefined humane endpoints. This acute mortality (10-15%) within phase A (initial 24-48 h post-fMCAo) (Figure 4a) was attributed to hemispheric edema and herniation resulting from large territorial strokes13, and was expected as part of translational stroke modeling. The delayed mortality during phase B (1/15 for cohort 1, 1/10 for cohort 2) added a maximum of 5-10% under the mSU protocol (Figure 4a) and usually occurs for animals with very large strokes that cannot be rescued despite mSU support. This also directly translates the severity-related human post-stroke mortality29. No application of mSU or low adherence to its principles results in increased Phase B mortality that can reach even 60-90%13. Phase C is normally devoid of further mortality.
Upon application of the mSU, mice with large strokes survive beyond the critical phase B and show significant neurological deficits. Our data showcase that the standardized use of fESS detects and quantifies both fMCAo-induced deficits and spontaneous improvement in mice (Figure 4b), and outperforms or matches previous scales like the focal Neuroscore (NS), the mNSS and the Bederson (BE) scales9,10,12,14. While not directly statistically comparable, the fESS shows similar or higher sensitivity in the acute phase, captures spontaneous neurological improvement after fMCAo, and remains deficit-sensitive up to 6 months post stroke, compared to the other scales. This supports its use for translational and sensitive scoring after mouse stroke and the present video-protocol ensures increased scoring objectivity.
In addition to the fESS, the Ladder-rung and Cylinder tests can complement long-term neurological scoring and monitoring by quantifying fore- and hindlimb paresis. Each test requires approximately 5-7 min per animal for video acquisition and 5-15 min for manual video analysis. Representative results are increased limb drops between the rungs as the mouse walks in the Ladder-rung test (resulting in right % lateralization for left stroke), and a "preferred" wall-touching with the healthy left forelimb for the Cylinder test (resulting in left % lateralization for left stroke). Our representative data for the 6-months´ cohort show that the Ladder-rung test can detect forelimb paresis in the acute/subacute phases but loses its sensitivity due to spontaneous improvement thereafter (Figure 4c, p<0.05 for time and p<0.01 for group difference, mixed-effects model), however remains more robust in detecting and quantifying hindlimb paresis for up to 6 months (Figure 4d, p<0.05 for group difference, mixed-effects model). In parallel, the Cylinder-test retains an excellent sensitivity in detecting forelimb paresis up to 6 months post-fMCAo (Figure 4e, p<0.001 for group difference, mixed-effects model). Combined, both tests effectively detect, quantify, and monitor long-term fore- and hind-limb paresis.
Figure 1. Post-fMCAo mSU support protocol. (A) Tools and materials used for mSU. (B) pulverizing of normal food (with food blender or other device) and making the gel-food for active (with syringe) and passive (petri dish) feeding support. (C) gel-food and solid pellets should be placed (and replaced freshly daily) in the cage of the animals few days prior (for accommodation) and after fMCAo; it is expected that the animals will hide the gel-food under bedding. (D) active grasping for syringe feeding (red arrows point at left cheek stabilization with fingers, arrowhead points at fur-grasping). (E) insertion of syringe in mouth, pointing at the right cheek (arrow). (F) Showcase of body surface temperature measurement (red area and arrow point at the center of ventral body for temperature measurement). (G) urethra plug (arrow). (H) Suggested timeline for chronic stroke experiments under mSU support (bsl: baseline, h: hours, d: days and m: months as evaluation timepoints), with suggested scoring using ESS, Ladder-rung and Cylinder tests. This timeline has been used here for cohorts 1 (6m follow-up) and 2 (14d follow-up). Please click here to view a larger version of this figure.
Figure 2. The experimental stroke scale. (A) Tools for ESS testing, (B) representative brain slices with stroke (left half, Nissl stain) and their corresponding overlap of the corresponding Allen Brain map, at bregma +1.0 and -0.3 mm anteroposteriorly (This figure has been modified from Allen Mouse Brain Atlas, mouse.brain-map.org and atlas.brain-map.org)30. (C) Animal suspension by its tail-base for forelimb, hindlimb and trunk symmetry tests of fESS, grey dotted circles show normal symmetry of fore- and hindlimbs. (D) Clear asymmetry of the paretic right hindlimb (asymmetric position/extension). (E) normal position of an animal on the beam. Please click here to view a larger version of this figure.
Figure 3. Setup of Ladder-rung and Cylinder tests. (A) setup of Cylinder test, a mouse is in the cylinder while vertical mirrors facilitate the 360° view of its forelimbs. (B) close view of the animal with a left forelimb contact (usage) to the cylinder wall. (C) view and design details of the Ladder-rung test for mice (see also text for dimensions and construction instructions); (C1) shows a normal mouse in the Ladder-rung corridor from above, (C2) shows a normal mouse with correct stepping on the rungs (no falls), (C3) shows a forelimb fall between the steps (images are captured from videos). Please click here to view a larger version of this figure.
Figure 4. Long-term survival and neurological deficits after fMCAo. (A) Replication of the mSU effectiveness in two independent animal cohorts: in the first one the mice were observed for 6 months and in the second animals were observed for 14 days following stroke. (B) Scores of different, well-established, neurological scales for both cohorts. (C) Forelimb and (D) hindlimb motor deficits of the right side (= right - left false steps, for fore- and hind-limbs respectively) detected by Ladder-rung test in our 6-months animal cohort, vs sham operated animals. (E) Forelimb asymmetry results (as % preference for usage of the healthy left forelimb) detected by Cylinder-test in our 6-months animal cohort, vs sham operated animals. Please click here to view a larger version of this figure.
Table 1. Software interface: Example of 3 animals with their daily calculation of RSS scores. Actions and RSS apply for Phase B and C. Please click here to download this Table.
Supplementary Figure S1. Definition of the daily Risk Stratification Score (RSS) and the resulting support actions for each animal. Animals with scores 0-1 have a minimal mortality risk while those with 5-6 a maximum one. Please click here to download this File.
Supplementary File 1. Proposed template for animal monitoring and documentation during the fMCAo operation and the mSU follow-up. Please click here to download this File.
Supplementary File 2. Proposed scoring sheet for the focal and general ESS. Please click here to download this File.
The present protocol is a comprehensive guide to the mSU support protocol, designed to reduce artifactual mortality between days 3-10 in mice subjected to large territorial strokes by the fMCAo model13. Additionally, the present protocol includes a standardized video guide for the focal component of the ESS scale (fESS) to reduce the extended subjectivity and bias of neurological focal scoring in mice after stroke. Alongside, we introduce the Ladder-rung test for quantifying long-term (up to 6 months) contralesional fore- and hind-limb motor deficits.
The mSU is user-friendly and effective. Our video aided protocol makes mSU clear for application even for non-experienced researchers. The 3 phases of mSU (namely phase A, B and C, see section 1 of protocol above and Figure 1h) are defined empirically for tailoring its assessment and supporting measures. The mSU tailors its interventions daily according to each phase and depending on each mouse´s Risk Stratification Score (RSS) score. This score reflects its clinical severity, gives an estimation for its actual risk for mortality, and guides its tailored support per mouse. Complementary to that, the mere clinical observation of the animal should always add information for tailored mSU support. Eventually, mSU translationally implements key components of human Stroke Unit (SU) support, including temperature control, fluid balance, infection prevention/treatment, nutritional support, and normoglycemia1,2,7, during the critical phase of the first 3-10 post-fMCAo days on mice13. Importantly, the effectiveness of mSU to reduce the artifactual mortality from 60-90% down to <15%13,31 has been successfully reproduced in independent research groups17,18,32,33.
Several critical steps are essential for the success of the mSU protocol. First, while mSU relies on close clinical observation and optimal animal support, it is advisable to have a team of at least two researchers working in shifts to reduce workload, although one researcher can also manage it alone. Second, the most critical timepoints for support are around 22:00 and 08:00, corresponding to the beginning and end of the nocturnal increase mouse activity, when energy demands are higher13,22,23. Third, in line with current clinical stroke guidelines7, glucose supplementation should be carefully tailored and minimal to avoid neurotoxic post-stroke hyperglycemia. Fourth, active feeding should be carried out in blocks of 5-10 animals administering mouthfuls of 40-60µl in steps, to balance reduced workload with effective feeding. Finally, the intensity of mSU has to be tailored to each mouse´s needs and RSS score, based on stroke severity. This practical means that mice with small strokes may need shorter and less intensive support, while those with larger strokes may need support even beyond day 14 to mitigate risk of death.
The neurological scoring in mice has always been highly subjective and challenging due to their small size and difficulty to detect deficits. Due to these, all previous stroke scales (BS, mBS, LS, mNSS, GS, NS, see also introduction) either detect crude signs (e.g., the 3- to 5-point scales of BS, mBS and LS), mix focal with general post-stroke symptoms (e.g., NS), fail to capture subtle deficits beyond the acute phase of stroke 8,9 (e.g., the 3-point BS 10, the 5-point mBS 11 or the 5-point LS6), or fail to quantify long-term spontaneous improvement after stroke. To improve all these, we previously13 developed the ESS (fESS/gESS) by critically combining or omitting components from previous scales, creating a tool capable of assessing commonly affected areas by the fMCAo model20 (Figure 2b). Now, we additionally provide the first video-standardization of fESS to offer visual guidance and resolve the long-standing limitation of subjectivity across laboratories and researchers. Our data support that the fESS outperforms the mBS and mNSS scales or equals the NS (Figure 4b) in detecting focal, stroke-related, deficits in mice while also capturing the ongoing long-term post-stroke spontaneous recovery. The provided video-standardization serves now as a reliable training tool for consistent evaluation of post-stroke deficits.
Supplementary to the fESS, we recommend using the Ladder-rung test and the previously described Cylinder test15 as a battery of tests to quantify forelimb and hindlimb paresis or corresponding improvements over the long-term (up to 6-months). For intra-animal limb analysis, baseline evaluations for both tests are necessary. The Ladder-rung test, previously used in rats 34,35, has been adapted and described here for mice. Practically, the test critically depends on a stable walking pattern in the rung-corridor, with no turnings or stops. For this, we recommend analyzing the second run in each time-point, as it typically yields the most stable walking patten. Proper training without habituation is crucial for reliable results, as outlined in the protocol above. A limitation of both Ladder-rung and Cylinder tests is that mice with large strokes may not move at all during phase A-B (days 3 and 7 in Figure 4c-e), thus providing no data and increasing variance; these mice often show maximum fault steps during phase C. To overcome this limitation and minimize stress of the animals we suggest testing mice from the end of Phase B onwards (e.g., > day 10). Another limitation is the fact that Ladder-rung test seems to lose its sensitivity for forelimb deficits´, but this is compensated by the Cylinder test. Eventually, these tests combined can objectively quantify both fore- and hindlimb deficits and their long-term spontaneous improvement.
In conclusion, we recommend the mSU as standard of care for translational mouse stroke models. At the same time, we recommend the accompanied ESS (fESS/gESS), Ladder-rung test and Cylinder test as an simple, time-efficient, cost-effective, quantitatively sensitive battery of tests to quantify long-term stroke deficits in mice. Eventually, mSU could be applied in the future in any other mouse model incorporating severe brain lesions (e.g. traumatic brain injury, models of brain hemorrhages, etc), where intense, clinically translational, mouse support is needed.
No disclosures to report.
We would like to thank Nikolaos Plakopitis and Ioannis Tatsidis for valuable surgical support during parts of the study.
Name | Company | Catalog Number | Comments |
Tools for mSU | |||
5% Dextrose solution | VIOSER S.A | na (not applicable) | Any genericon |
Contactless Digital Thermometer | AVRON | YTC20095 | Any genericon |
Digital weight scale | KERN & Sohn Gmbh | FCB6K1 | Any genericon |
Food pellets | Mucedola srl | na | Any genericon, use the normal food of your animal facility |
Heating Plate | Photax | na | Photax dishwarmer 2 |
Liquid antiseptic | Schülke & Mayr GmbH | na | Octenisept® |
Normal food blender | na | For pellet pulverizing. Any genericon | |
Normal saline | DEMO S.A. | na | Sodium Chloride Injection 0,9% |
Pinsetter and cotton buds | na | Any genericon | |
Sugar | na | Any genericon | |
Syringes (1ml) with 27-gauge needle | na | Any genericon. For food administration (without needle) and for subcutaneous fluid administration (with needle) | |
Tools for ESS | |||
45° angled surface | construct it | na | Made out of plexiglas or other material, with rubber-surface, for climbing tests |
cotton swab | Any genericon | na | commercial ear cotton buds, make its cotton tip long and thinned |
edge-sharpened wooden stick | Any genericon | na | e.g. toothpicks |
Long beam | construct it | na | Dimensions: 1 x 1 x1cm, approximately 100cm long, wooden. Place between two table-edges for beam walking test |
Thick glove | Any genericon | na | to prevent animal trauma when falling from beam |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone